Get informed and Get your Share! Medium-cap Small-cap Large-cap 10/19/26 FITB Fifth Third Bancorp STLD Steel Dynamics WRB W.R. Berkley SMMT Summit Therapeutics CCK Crown Holdings AGNC AGNC Investment 10/20/26 GE GE Aerospace NFLX Netflix RTX RTX Corporation ISRG Intuitive Surgical CB Chubb Limited COF Capital One Financial MMM 3M GM General Motors NOC Northrop… Continue reading Quarterly Reports 2026 10/19 – 10/23 Week 43

The global technology sector suffered another sharp setback on Thursday, October 15, as investors continued pulling money out of semiconductor manufacturers and other companies tied to the artificial intelligence boom. What began as a retreat from highly valued technology stocks on Wall Street quickly spread across Asia and Europe, raising fresh questions about whether the… Continue reading Global Chip Sell-Off Deepens as Investors Question the AI Boom

The artificial intelligence industry is facing growing scrutiny from investors as concerns about the cost of developing AI, the profitability of its applications and the valuations of leading technology companies weigh on the stock market. What began as enthusiasm over a transformative technology has increasingly become a debate over whether the companies building the AI… Continue reading AI Stock Sell-Off Fears Grow as Investors Question the Trillion-Dollar Boom

10/15/2026 Iambic Therapeutics (IAM) Price Range: $15.00 – $17.00 10/16/2026 City Therapeutics (CTY) Price Range: $17.00 – $19.00 Note: Micro-cap and small-cap offerings frequently experience sudden day-of delays or timeline extensions based on underwriter clearing. Keep a close eye on your brokerage platform if you intend to trade the debut.

Get informed and Get your Share! Medium-cap Small-cap Large-cap 10/13/26 JPM JPMorgan Chase & Co. JNJ Johnson & Johnson UNH UnitedHealth Group GS The Goldman Sachs Group WFC Wells Fargo & Company C Citigroup DPZ Domino’s Pizza 10/14/26 ASML ASML Holding BAC Bank of America MS Morgan Stanley BLK BlackRock PGR The Progressive FAST Fastenal… Continue reading Quarterly Reports 2026 10/12 – 10/16 Week 42

For investors looking to build wealth over decades, dividend-paying stocks can be an attractive part of a portfolio. They offer something that stocks without dividends do not: a stream of cash payments simply for owning shares. But that does not automatically make dividend stocks better investments. The real question is whether an investor should prioritize… Continue reading Dividend Stocks: Can They Really Build a Lifetime of Passive Income?

For years, marijuana policy in the United States has existed in an unusual gray area. More than half of the states allow marijuana for medical purposes, many also permit recreational use, and the legal cannabis industry has grown into a multibillion-dollar business. Yet under federal law, marijuana has remained a controlled substance, creating a persistent… Continue reading Is Marijuana Finally Headed for Federal Legalization?

10/9/2026 TRex Bio (TRXB) Price Range: $14.00 – $16.00 Retension Pharmaceuticals (RTSN) Price Range: $11.00 – $13.00 Note: Micro-cap and small-cap offerings frequently experience sudden day-of delays or timeline extensions based on underwriter clearing. Keep a close eye on your brokerage platform if you intend to trade the debut.

Get informed and Get your Share! Medium-cap Small-cap Large-cap 10/06/26 STZ Constellation Brands RPM RPM International 10/08/26 PEP PepsiCo 10/09/26 DAL Delta Air Lines Medium-cap 10/05/26 AEHR Aehr Test Systems 10/06/26 LW Lamb Weston PENG Penguin Solutions, Inc. NEOG Neogen 10/07/26 LEVI Levi Strauss & Co. APLD Applied Digital Corporation 10/08/26 NG Novagold Resources NRIX… Continue reading Quarterly Reports 2026 10/5 – 10/9 Week 41

OpenAI has halted plans to release its next-generation GPT-6.1 Astra model after internal testing found that the system did not meet the company’s standards for safety and alignment. The decision, announced September 28, represents an unusual moment for the rapidly advancing artificial-intelligence industry: a major AI developer has decided that a more capable model is… Continue reading OpenAI Holds Back New AI Model as Safety Concerns Escalate Across the Industry